In the present study, we used clinical and molecular data from the dataset of The Cancer Genome Atlas for Thyroid Cancer (TCGA-THCA) to explore potential pathways associated with the loss of NIS expression. This evidence concerns the gene SLC5A5 and thyroid gland carcinoma.